Ligatech awarded 2024 "Science and Technology Innovation Action Plan" Science and Technology Little Giant Project

2025-03-11

Good news! Recently, Ligatech has successfully approved the Shanghai 2024 "Science and Technology Innovation Action Plan" Science and Technology Little Giant Project, thanks to its outstanding technological innovation capabilities and rapid development trend in the field of sports medicine! This is a full affirmation of Ligatech's long-term commitment to technological innovation and deep cultivation in the field of sports medicine, as well as a high recognition of the company's future development potential!

Serial Number：37    Applicant：Shanghai Ligatech Bioscience Co., Ltd.

The "Shanghai Science and Technology Little Giant Project" is organized and implemented by the Shanghai Science and Technology Commission, aiming to cultivate and support technology-based enterprises with strong innovation capabilities and high growth potential in the city. The successful establishment of this project signifies that Ligatech has reached a leading level in technology innovation, product research and development, and market expansion in the industry.

About Us

Since its establishment in 2014, Ligatech has always adhered to the principle of "becoming a leader in the field of sports medicine" and focused on the research and promotion of this field. Ligatech has a team of high-quality R&D talents and has established close industry university research cooperation relationships with multiple research universities and institutions. As of now, the company has obtained a total of 93 patent authorizations and successfully developed core technology products with independent intellectual property rights such as artificial ligaments, achieving significant application results in the field of sports medicine. The company has established industry university research cooperation relationships with multiple research universities and institutions, and has undertaken city level scientific and technological innovation projects multiple times. In recent years, it has won titles such as "High tech Enterprise", "Specialized, Refined, Unique and New Small Giant Enterprise", "Shanghai Patent Pilot Unit", "Qingpu District Patent Demonstration Unit", and "Qingpu District Enterprise Technology Center".

Mr. Yuan Zheng, Chairman and General Manager, has repeatedly emphasized that "doing business is not about making quick money, but about running far." Ligatech has always been patient oriented, lowering the threshold for medical care through technological innovation. Ligatech's mission is not only to provide efficient treatment solutions for patients, but also to bridge the gap in medical standards between impoverished and developed areas through technological innovation.

Winning the title of "Shanghai Science and Technology Little Giant Cultivation Enterprise" this time is the starting point of Ligatech's new journey. In the future, the company will continue to enhance its independent innovation capabilities, give back to customers with higher quality products and services, and make greater contributions to promoting technological progress and industrial development in the field of sports medicine!